Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China flag China · Delayed Price · Currency is CNY
28.71
-0.40 (-1.37%)
At close: Feb 12, 2026

SHE:301584 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,9501,7881,4871,051577.97681.74
Cash & Short-Term Investments
1,9501,7881,4871,051577.97681.74
Cash Growth
31.12%20.24%41.54%81.80%-15.22%6.28%
Accounts Receivable
8,1286,5936,1525,3925,1415,446
Other Receivables
169.46142.83145.8175.31.482.55
Receivables
8,2986,7366,2985,4685,1425,448
Inventory
3,2873,4792,5131,8411,229491.11
Other Current Assets
641.03593.16448.18419430.07264.03
Total Current Assets
14,17612,59610,7468,7787,3796,885
Property, Plant & Equipment
271.95289.54236.6135.71104.0752.03
Goodwill
37.3140.240.237.3137.3137.31
Other Intangible Assets
9.65.737.337.377.929.21
Long-Term Accounts Receivable
21.5322.2214.254.1423.4436.18
Long-Term Deferred Tax Assets
91.0380.0572.0169.6248.4632.75
Long-Term Deferred Charges
75.7668.1946.8119.964.476.46
Other Long-Term Assets
3.1710.548.264.5--
Total Assets
14,68613,11211,1719,0577,6057,059
Accounts Payable
7,4086,3175,2304,5624,8295,022
Accrued Expenses
106.89217.45209.15177.39150.7285.27
Short-Term Debt
3,7723,8543,5282,3881,027144.64
Current Portion of Long-Term Debt
48.84---154.06-
Current Portion of Leases
----24.51-
Current Income Taxes Payable
86.5534.4632.0228.8326.4726.99
Current Unearned Revenue
482.17558.46405.48414.89182.06129.15
Other Current Liabilities
263.02261.81201.25177.4586.37382.86
Total Current Liabilities
12,16711,2439,6067,7496,4815,791
Long-Term Debt
23.1823.1869.53115.8889.22-
Long-Term Leases
75.3968.6863.1248.1627.943.22
Long-Term Unearned Revenue
0.010.010.05---
Pension & Post-Retirement Benefits
-----7.3
Long-Term Deferred Tax Liabilities
0.360.631.280.020.470.75
Other Long-Term Liabilities
---1.2113.9716.88
Total Liabilities
12,26611,3359,7407,9146,6125,819
Common Stock
421.29358.1358.1358.1358.1223.81
Additional Paid-In Capital
341.238.2336.7131.3626.28512.18
Retained Earnings
1,3151,085856.59660.29557.63448.88
Total Common Equity
2,0771,4811,2511,050942.011,185
Minority Interest
342.73295.37179.9592.7350.9455.36
Shareholders' Equity
2,4201,7771,4311,142992.951,240
Total Liabilities & Equity
14,68613,11211,1719,0577,6057,059
Total Debt
3,9193,9463,6612,5521,323147.86
Net Cash (Debt)
-1,969-2,157-2,174-1,501-744.9533.88
Net Cash Growth
------15.23%
Net Cash Per Share
-5.53-6.05-6.09-4.22-2.101.50
Filing Date Shares Outstanding
356.1358.1356.92355.67358.1354.83
Total Common Shares Outstanding
356.1358.1356.92355.67358.1354.83
Working Capital
2,0091,3531,1401,029898.881,094
Book Value Per Share
5.834.143.512.952.633.34
Tangible Book Value
2,0301,4351,2041,005896.781,138
Tangible Book Value Per Share
5.704.013.372.832.503.21
Buildings
-45.3345.3345.3345.3345.33
Machinery
-192.42116.8635.614.1317.33
Construction In Progress
-1.411.13-1.54-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.